Prodia Diagnostic Line is trading at IDR 197.00, down 3.43%, after continued selling following weak first-half 2026 results.
- Revenue fell 51.89% year over year to Rp13.70 billion; the company reported an Rp8.84 billion net loss, reversing a Rp5.31 billion profit.
- No new company-specific announcement dated September 22, 2026 was found; the decline appears to extend the negative reaction to July results.
- Planned product additions and market expansion remain in focus.